Caribou Biosciences, Inc. (CRBU) stock
CRBUNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3073% below fair value
$0.35−0.01 (-2.51%)
Close on Nov 16, 2026Market cap $37.82MP/E –Yield –
Caribou Biosciences profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Caribou Biosciences's profit margin for the twelve months ending Jun 30, 2026 was -1030.4%. For fiscal 2025 it was -1327.4%, against -1491.9% the year before. The highest annual figure on record is -277.6% in fiscal 2020.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -1327.4% | +164.5 |
| FY2024 | Dec 31, 2024 | -1491.9% | −1195.9 |
| FY2023 | Dec 31, 2023 | -296.1% | +421.7 |
| FY2022 | Dec 31, 2022 | -717.8% | −20.5 |
| FY2021 | Dec 31, 2021 | -697.3% | −419.7 |
| FY2020 | Dec 31, 2020 | -277.6% | +127.3 |
| FY2019 | Dec 31, 2019 | -404.8% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -1619.9% | +408.5 |
| Q1 FY2026 | Mar 31, 2026 | -1046.5% | +653.1 |
| Q4 FY2025 | Dec 31, 2025 | -672.1% | +1036.6 |
| Q3 FY2025 | Sep 30, 2025 | -1253.3% | +460.3 |
| Q2 FY2025 | Jun 30, 2025 | -2028.4% | −940.2 |
| Q1 FY2025 | Mar 31, 2025 | -1699.6% | −2.0 |
| Q4 FY2024 | Dec 31, 2024 | -1708.7% | −738.9 |
| Q3 FY2024 | Sep 30, 2024 | -1713.6% | −1671.4 |
| Q2 FY2024 | Jun 30, 2024 | -1088.3% | −302.1 |
| Q1 FY2024 | Mar 31, 2024 | -1697.6% | −896.8 |
| Q4 FY2023 | Dec 31, 2023 | -969.8% | −238.8 |
| Q3 FY2023 | Sep 30, 2023 | -42.3% | +764.5 |
| Q2 FY2023 | Jun 30, 2023 | -786.1% | −149.3 |
| Q1 FY2023 | Mar 31, 2023 | -800.8% | −84.3 |
| Q4 FY2022 | Dec 31, 2022 | -731.0% | −8.9 |
| Q3 FY2022 | Sep 30, 2022 | -806.8% | −279.4 |
| Q2 FY2022 | Jun 30, 2022 | -636.9% | +332.7 |
| Q1 FY2022 | Mar 31, 2022 | -716.5% | +113.2 |
| Q4 FY2021 | Dec 31, 2021 | -722.1% | +772.1 |
| Q3 FY2021 | Sep 30, 2021 | -527.4% | +134.8 |
| Q2 FY2021 | Jun 30, 2021 | -969.6% | −947.5 |
| Q1 FY2021 | Mar 31, 2021 | -829.7% | −253.6 |
| Q4 FY2020 | Dec 31, 2020 | -1494.2% | – |
| Q3 FY2020 | Sep 30, 2020 | -662.2% | – |
| Q2 FY2020 | Jun 30, 2020 | -22.1% | – |
| Q1 FY2020 | Mar 31, 2020 | -576.1% | – |
See a number that looks wrong?